InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Gary Ainsworth as Vice President, Market Access
Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Gary Ainsworth as Vice President, Market Access, as the company prepares for the potential FDA approval of TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA decision date set for Aug. 15, 2025. Ainsworth brings extensive experience from roles at Eversana Intouch, Havas Gemini, Baxter International, Roche Laboratories, and Sanofi, where he developed market access strategies and payer-focused…